Holen Sie sich die Stockscreener-App
328.02
0.04%
-0.18
Schlusskurs vom Vortag:
$328.20
Offen:
$329.5
24-Stunden-Volumen:
658.80K
Relative Volume:
0.68
Marktkapitalisierung:
$12.87B
Einnahmen:
$1.40B
Nettoeinkommen (Verlust:
$177.69M
KGV:
72.52
EPS:
4.5234
Netto-Cashflow:
$174.93M
1W Leistung:
-1.82%
1M Leistung:
-4.74%
6M Leistung:
+29.51%
1J Leistung:
+22.69%
1-Tages-Spanne:
$326.60
$329.50
1-Wochen-Bereich:
$326.58
$337.76
52-Wochen-Spanne:
$221.26
$362.41
Penumbra Inc Stock (PEN) Company Profile
Firmenname
Penumbra Inc
Sektor
Branche
Telefon
(510) 995-2486
Adresse
ONE PENUMBRA PLACE, ALAMEDA, CA
Compare PEN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
328.03 | 12.88B | 1.40B | 177.69M | 174.93M | 4.5234 |
ABT
Abbott Laboratories
|
102.51 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.77 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.69 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.59 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-11-18 | Eingeleitet | Wells Fargo | Underweight |
| 2025-10-08 | Hochstufung | Needham | Hold → Buy |
| 2025-09-02 | Eingeleitet | Evercore ISI | Outperform |
| 2025-03-14 | Eingeleitet | BofA Securities | Buy |
| 2025-01-21 | Eingeleitet | UBS | Buy |
| 2024-12-17 | Eingeleitet | Oppenheimer | Outperform |
| 2024-12-11 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-09-18 | Eingeleitet | Stifel | Buy |
| 2024-09-03 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-31 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-07-31 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-02-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-09-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-03-29 | Herabstufung | Needham | Buy → Hold |
| 2023-01-30 | Eingeleitet | Piper Sandler | Overweight |
| 2022-11-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-10-05 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-09 | Hochstufung | Needham | Hold → Buy |
| 2022-07-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-04-19 | Eingeleitet | Deutsche Bank | Buy |
| 2022-03-08 | Eingeleitet | Needham | Hold |
| 2021-09-16 | Eingeleitet | Truist | Buy |
| 2021-06-04 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-12-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-10-07 | Fortgesetzt | Canaccord Genuity | Buy |
| 2020-09-29 | Eingeleitet | BTIG Research | Buy |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2019-06-13 | Bestätigt | BofA/Merrill | Buy |
| 2019-05-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-05-21 | Eingeleitet | William Blair | Outperform |
| 2018-10-29 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-10-08 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2018-02-21 | Eingeleitet | William Blair | Outperform |
| 2018-01-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2015-11-30 | Bestätigt | Canaccord Genuity | Buy |
| 2015-10-13 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Penumbra Inc Aktie (PEN) Neueste Nachrichten
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-SLAB, PEN, SKYT, and EHAB - The Malaysian Reserve
Penumbra (PEN) down 1.6% since last earnings report: Can it rebound? - MSN
Dow Update: What is the long term forecast for Penumbra Inc stockGlobal Markets & Verified Entry Point Detection - baoquankhu1.vn
Assessing Penumbra (PEN) Valuation As Shares Trade On A High P/E Multiple - Yahoo Finance
Vanguard disaggregates holdings; reports 0 shares in Penumbra (PEN) - Stock Titan
Penumbra (PEN) Down 1.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Reasons to Keep Penumbra Shares in Your Portfolio at This Time - Bitget
Reasons to Retain Penumbra Stock in Your Portfolio for Now - TradingView
Penumbra Inc Stock: Boston Scientific Merger Agreement Reshapes Investor Outlook for US70975L1070 Sh - AD HOC NEWS
PFM Health Sciences, LP's Penumbra Inc(PEN) Holding History - GuruFocus
Discipline and Rules-Based Execution in PEN Response - Stock Traders Daily
Congress Asset Management Co. Trims Stake in Penumbra, Inc. $PEN - MarketBeat
Penumbra Inc (NYSE:PEN) Devices Makes Waves Across Russell 1000 Healthcare Stocks - Kalkine Media
Penumbra, Inc. (NYSE:PEN) Given Average Rating of "Hold" by Brokerages - MarketBeat
Investment Report: How correlated is Penumbra Inc to the S P5002026 Historical Comparison & Expert Curated Trade Setups - baoquankhu1.vn
EV Market: Is Penumbra Inc likely to announce a buybackDollar Strength & Daily Entry Point Trade Alerts - baoquankhu1.vn
PEN Stock Price, Quote & Chart | PENUMBRA INC (NYSE:PEN) - ChartMill
Bank Watch: What is the long term forecast for Penumbra Inc stockEarnings Overview Summary & Accurate Entry/Exit Alerts - baoquankhu1.vn
Penumbra Inc (NYSE:PEN) Combines Strong Growth with Bullish Chart Setup - ChartMill
Penumbra, Inc. (PEN): A bull case theory - MSN
Penumbra (PEN) president has 117 shares withheld for RSU tax obligations - Stock Titan
Penumbra (PEN) EVP has 186 shares withheld to cover RSU taxes - Stock Titan
Risk Off: Is Penumbra Inc impacted by rising ratesWeekly Stock Analysis & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Is Penumbra (PEN) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
UBS reiterates Penumbra stock rating on thrombectomy confidence By Investing.com - Investing.com India
UBS reiterates Penumbra stock rating on thrombectomy confidence - Investing.com
What Makes Penumbra (PEN) a Good Investment Choice? - Insider Monkey
Delta Global Management LP Acquires 7,896 Shares in Penumbra, Inc. - National Today
Jain Global LLC Boosts Stock Position in Penumbra, Inc. $PEN - MarketBeat
Holocene Advisors LP Makes New Investment in Penumbra, Inc. $PEN - MarketBeat
Delta Global Management LP Purchases Shares of 7,896 Penumbra, Inc. $PEN - MarketBeat
Cinctive Capital Management LP Buys Shares of 6,215 Penumbra, Inc. $PEN - MarketBeat
Bamco Inc. NY Has $3.42 Million Position in Penumbra, Inc. $PEN - MarketBeat
Algert Global LLC Buys 12,830 Shares of Penumbra, Inc. $PEN - MarketBeat
Braidwell LP Has $35.85 Million Stock Position in Penumbra, Inc. $PEN - MarketBeat
Is It Too Late To Consider Penumbra (PEN) After Strong Multi‑Year Share Price Gains? - Yahoo Finance
Integral Health Asset Management LLC Has $12.67 Million Stock Position in Penumbra, Inc. $PEN - MarketBeat
Is It Too Late To Consider Penumbra (PEN) After Strong 1 Year Share Price Gains? - simplywall.st
Magnetar Financial LLC Sells 26,473 Shares of Penumbra, Inc. $PEN - MarketBeat
Capital World Investors Sells 129,455 Shares of Penumbra, Inc. $PEN - MarketBeat
Risk Report: Is Penumbra Inc likely to announce a buybackBreakout Watch & Smart Allocation Stock Reports - baoquankhu1.vn
Can Penumbra Inc. (0P8) stock sustain double digit ROEEntry Point & Daily Risk Controlled Trade Plans - Naître et grandir
Gap Down: What is Penumbra Inc. s debt to equity ratio2025 Trading Recap & Community Consensus Trade Signals - baoquankhu1.vn
Analyst Downgrade: Will Penumbra Inc. stock rally after Fed decisions2025 Dividend Review & Expert Curated Trade Ideas - Naître et grandir
Aug Shorts: What is the long term forecast for Penumbra Inc stock2025 Technical Patterns & Expert Approved Trade Ideas - baoquankhu1.vn
Picton Mahoney Asset Management Takes $1.03 Million Position in Penumbra, Inc. $PEN - MarketBeat
3 Reasons Boston Scientific Stock Could Quietly 5X as the World Ages - The Motley Fool
Blood Clot Retrieval Devices Market Size, Share & Forecast to 2036 - Fact.MR
Insider Sell: Maggie Yuen Sells Shares of Penumbra Inc (PEN) - GuruFocus
Insider Selling: Penumbra (NYSE:PEN) CFO Sells 2,432 Shares of Stock - MarketBeat
Penumbra (PEN) CFO sells 2,432 shares under Rule 10b5-1 plan - Stock Titan
Finanzdaten der Penumbra Inc-Aktie (PEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):